Tariq Jamal Siddiqi, Stefan D Anker, Gerasimos Filippatos, João Pedro Ferreira, Stuart J Pocock, Michael Böhm, Martina Brueckmann, Vijay K Chopra, Tomoko Iwata, James Januzzi, Ileana L Piña, Piotr Ponikowski, Michele Senni, Ola Vedin, Subodh Verma, Yuhui Zhang, Faiez Zannad, Milton Packer, Javed Butler
AIMS: There are limited data on health status and changes in it over time across major subgroups of patients with heart failure and preserved ejection fraction (HFpEF), including ejection fraction spectrum, age, sex, region, body mass index (BMI), and comorbidities including diabetes, chronic kidney disease (CKD), anemia, and atrial fibrillation/flutter. METHODS AND RESULTS: In the EMPEROR-Preserved trial, Kansas City Cardiomyopathy Questionnaire (KCCQ) was assessed at baseline, 12-, 32- and 52-weeks...
March 28, 2023: European Journal of Heart Failure